Invest now
Aarti Drugs share price
Balanced risk
You have to be logged in to add this to Watchlist.- ₹417.05(-2.40%)August 14, 2026 15:51:29 PM IST
- NSE
- BSE
- Vol : 171.96 K (NSE + BSE)Last 20 day avg : 243.56 K
Aarti Drugs is trading -2.40% lower at Rs 417.05 as compared to its last closing price. Aarti Drugs has been trading in the price range of 429.95 & 413.95. Aarti Drugs has given 3.90% in this year & 4.10% in the last 5 days. Aarti Drugs has TTM P/E ratio 18.06 as compared to the sector P/E of 33.00.There are 1 analysts who have initiated coverage on Aarti Drugs. There are 0.00 analysts who have given it a strong buy rating & 0.00 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 50.17 Crores in its last quarter.The Mutual Fund holding in Aarti Drugs was at 10.08% in 30 Jun 2026. The MF holding has decreased from the last quarter. The FII holding in Aarti Drugs was at 1.52% in 30 Jun 2026. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 16 Aug 2026, 01:31 PM IST
- BetaMedium volatility1.04Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.37The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.47Annual dividends as a percentage of the stock price.
- P/BLower than historical values2.52The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/ELower than historical values20.43Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates overvaluation3.43The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Aarti Drugs News
Mutual Fund Ownership
View allAarti Drugs Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-07-31 | Quarterly Results |
| 2026-05-15 | Audited Results |
| 2026-02-03 | Quarterly Results & Interim Dividend |
| 2025-11-07 | Quarterly Results |
| 2025-07-18 | Quarterly Results |
About the company Aarti Drugs
- IndustryBiotechnology & Drugs
- ISININE767A01016
- BSE Code524348
- NSE CodeAARTIDRUGS
Aarti Drugs Share Price FAQs
Aarti Drugs is trading at 417.05 as on Fri Aug 14 2026 10:21:29. This is -2.40% lower as compared to its previous closing price of 427.30.
The market capitalization of Aarti Drugs is 3795.76 Cr as on Fri Aug 14 2026 10:21:29.
The average broker rating on Aarti Drugs is Hold. The breakup of analyst rating is given below -
- 0.00 analysts have given a strong buy rating
- 0.00 analysts have given a buy rating
- 1 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Aarti Drugs is 534.15 whereas the 52 wk low is 318.60
Aarti Drugs can be analyzed on the following key metrics -
- TTM P/E: 18.06
- Sector P/E: 33.00
- Dividend Yield: 0.47%
- D/E ratio: -
Aarti Drugs reported a net profit of 194.92 Cr in 2026.
The Mutual Fund Shareholding was 10.08% at the end of 30 Jun 2026.
Quick Links
EQUITY QUICK LINKS
Aarti Drugs QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.